Nalaganje...

Getting personal with myelodysplastic syndromes: is now the right time?

INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Expert Rev Hematol
Main Authors: Chokr, Nora, Pine, Alexander B., Bewersdorf, Jan Philipp, Shallis, Rory M., Stahl, Maximilian, Zeidan, Amer M.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/
https://ncbi.nlm.nih.gov/pubmed/30977414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673
Oznake: Označite
Brez oznak, prvi označite!